McKesson Corporation (BIT:1MCK)

Market Cap	78.53B
Revenue (ttm)	332.83B
Net Income (ttm)	2.73B
Shares Out	n/a
EPS (ttm)	21.08
PE Ratio	28.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	626.00
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
RSI	n/a
Earnings Date	May 8, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 51,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1MCK

Financial Performance

In 2023, McKesson's revenue was $308.95 billion, an increase of 11.65% compared to the previous year's $276.71 billion. Earnings were $3.00 billion, a decrease of -15.67%.

Financial numbers in USD